AlphaGrep UK Ltd’s Roivant Sciences ROIV Stock Holding History

AlphaGrep UK Ltd’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$883K	Buy	31,871 +12,934	+68%	+$332K	0.26%	42
2025 Q4	$411K	Buy	+18,937	New	+$374K	0.14%	275

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AlphaGrep UK Ltd's ROIV Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Roivant Sciences (ROIV) stake by 68% in Q1 2026, buying an estimated $332K and bringing the position to 31,871 shares worth $883K. The position accounts for 0.26% of the portfolio, ranked #42.

AlphaGrep UK Ltd first reported a position in ROIV in Q4 2025 and has held it in 2 quarters since. 442 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

AlphaGrep UK Ltd held 31,871 shares of Roivant Sciences worth $883K as of Q1 2026.
AlphaGrep UK Ltd bought 12,934 Roivant Sciences shares in Q1 2026, an estimated $332K.
Roivant Sciences made up 0.26% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #42 holding.
AlphaGrep UK Ltd first reported a position in Roivant Sciences in Q4 2025 and has held it in 2 quarters since.
442 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.